Home > Insider Trading > Filing (0000899243-19-019602)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1061027	Sunesis Pharmaceuticals Inc	SNSS	Pharmaceutical Preparations (2834)	943295878

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1172252	N Andrew Schiff	C/O Aisling Capital Management Lp 888 Seventh Ave., 12Th Floor New York NY 10106	No	No	Yes	No
1250195	Steve Elms	C/O Aisling Capital Management Lp 888 Seventh Ave., 12Th Floor New York NY 10106	No	No	Yes	No
1652910	Aisling Capital Iv, Lp	C/O Aisling Capital Management Lp 888 Seventh Avenue, 12Th Floor New York NY 10106	No	No	Yes	No
1737019	Aisling Capital Partners Iv Llc	C/O Aisling Capital Management Lp 888 Seventh Ave., 12Th Floor New York NY 10106	No	No	Yes	No
1737020	Aisling Capital Partners Iv, Lp	C/O Aisling Capital Management Lp 888 Seventh Ave., 12Th Floor New York NY 10106	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-07-15	2,500,000	$0.60	10,100,000	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnote

Footnotes

Shares held by Aisling Capital IV, LP ("Aisling"). Aisling Capital Partners IV, LP ("Aisling GP"), is the general partner of Aisling. Aisling Capital Partners IV LLC ("Aisling Partners"), is the general partner of Aisling GP. The individual managing members ("the Aisling Managers"), of Aisling Partners are Andrew Schiff, M.D. and Steve Elms. By virtue of these relationships, Aisling GP, Aisling Partners and the Aisling Managers may be deemed to have voting and investment power over the shares held by Aisling. Each of the reporting persons, other than Aisling, disclaims beneficial ownership of the shares held by Aisling, except to the extent of any pecuniary interest therein, if any.